Search research articles
Contact Us
Filters
Showing results (81-90 of 216) with videos related to
Page
of 22
Sort By:
The Journal of Clinical Investigation
|
September 3, 2024
Pharmacologic LDH inhibition redirects intratumoral glucose uptake and improves antitumor immunity in solid tumor models
Svena Verma, Sadna Budhu, Inna Serganova, et al.
Nature
|
November 14, 2017
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
Marta Łuksza, Nadeem Riaz, Vladimir Makarov, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 11, 2015
IL-6/NOS2 inflammatory signals regulate MMP-9 and MMP-2 activity and disease outcome in nasopharyngeal carcinoma patients
Ahmed-Amine Zergoun, Abderezak Zebboudj, Sarah Leila Sellam, et al.
The Journal of Experimental Medicine
|
September 26, 2012
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype
Daniel Hirschhorn-Cymerman, Sadna Budhu, Shigehisa Kitano, et al.
Oncotarget
|
December 30, 2017
Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation
Parisa Momtaz, James J Harding, Charlotte Ariyan, et al.
Histopathology
|
February 22, 2019
Massively parallel sequencing analysis of benign melanocytic naevi
John R Lozada, Felipe C Geyer, Pier Selenica, et al.
Cancer Immunology Research
|
June 17, 2024
Intermittent MEK Inhibition with GITR Costimulation Rescues T-cell Function for Increased Efficacy with CTLA-4 Blockade in Solid Tumor Models
Lauren Dong, Hyejin Choi, Sadna Budhu, et al.
Cancer Research
|
December 17, 2011
Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment
Alexander M Lesokhin, Tobias M Hohl, Shigehisa Kitano, et al.
The Journal of Experimental Medicine
|
April 1, 2009
Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response
Gabrielle A Rizzuto, Taha Merghoub, Daniel Hirschhorn-Cymerman, et al.
Nature
|
May 18, 2017
Chromatin states define tumour-specific T cell dysfunction and reprogramming
Mary Philip, Lauren Fairchild, Liping Sun, et al.
Page
of 22
Search research articles
Search
Showing results (81-90 of 216) with videos related to
Sort By:
Page
of 22
The Journal of Clinical Investigation
|
September 3, 2024
Pharmacologic LDH inhibition redirects intratumoral glucose uptake and improves antitumor immunity in solid tumor models
Svena Verma, Sadna Budhu, Inna Serganova, et al.
Nature
|
November 14, 2017
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
Marta Łuksza, Nadeem Riaz, Vladimir Makarov, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 11, 2015
IL-6/NOS2 inflammatory signals regulate MMP-9 and MMP-2 activity and disease outcome in nasopharyngeal carcinoma patients
Ahmed-Amine Zergoun, Abderezak Zebboudj, Sarah Leila Sellam, et al.
The Journal of Experimental Medicine
|
September 26, 2012
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype
Daniel Hirschhorn-Cymerman, Sadna Budhu, Shigehisa Kitano, et al.
Oncotarget
|
December 30, 2017
Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation
Parisa Momtaz, James J Harding, Charlotte Ariyan, et al.
Histopathology
|
February 22, 2019
Massively parallel sequencing analysis of benign melanocytic naevi
John R Lozada, Felipe C Geyer, Pier Selenica, et al.
Cancer Immunology Research
|
June 17, 2024
Intermittent MEK Inhibition with GITR Costimulation Rescues T-cell Function for Increased Efficacy with CTLA-4 Blockade in Solid Tumor Models
Lauren Dong, Hyejin Choi, Sadna Budhu, et al.
Cancer Research
|
December 17, 2011
Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment
Alexander M Lesokhin, Tobias M Hohl, Shigehisa Kitano, et al.
The Journal of Experimental Medicine
|
April 1, 2009
Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response
Gabrielle A Rizzuto, Taha Merghoub, Daniel Hirschhorn-Cymerman, et al.
Nature
|
May 18, 2017
Chromatin states define tumour-specific T cell dysfunction and reprogramming
Mary Philip, Lauren Fairchild, Liping Sun, et al.
Page
of 22